We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.23B
AUM Growth
+$298M
(+4.3%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
2.07%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
1,100
New
151
Increased
415
Reduced
333
Closed
164
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$40.6M |
| 2 |
Autodesk
ADSK
|
+$38.8M |
| 3 |
Intuit
INTU
|
+$37.1M |
| 4 |
Ecolab
ECL
|
+$35.6M |
| 5 |
Coca-Cola
KO
|
+$35.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$51.9M |
| 2 |
EOG Resources
EOG
|
+$33.8M |
| 3 |
DATA
Tableau Software, Inc.
DATA
|
+$32M |
| 4 |
Microsoft
MSFT
|
+$29.8M |
| 5 |
Ford
F
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 17.68% |
| 3 | Consumer Discretionary | 13.74% |
| 4 | Industrials | 11.53% |
| 5 | Healthcare | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SHYF
576
DELISTED
The Shyft Group
SHYF
| $1.45M | 0.02% |
132,144
+109,144
| +475% | +$1.01M |
|
|
ESPR
577
DELISTED
Esperion Therapeutics
ESPR
| $1.44M | 0.02% |
31,050
-670
| -2% | -$31.5K |
|
578
Amphastar Pharmaceuticals
AMPH
$825M
| $1.44M | 0.02% |
68,132
-4,821
| -7% | -$101K |
|
579
Conduent
CNDT
$230M
| $1.44M | 0.02% |
+149,600
| New | +$1.62M |
|
580
Modine Manufacturing
MOD
$12.8B
| $1.43M | 0.02% |
100,056
+2,442
| +3% | +$34.9K |
|
581
Automatic Data Processing
ADP
$100B
| $1.4M | 0.02% |
8,490
+500
| +6% | +$81.2K |
|
582
Zumiez
ZUMZ
$320M
| $1.39M | 0.02% |
53,310
+7,190
| +16% | +$175K |
|
|
ODT
583
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $1.39M | 0.02% |
37,923
-2,194
| -5% | -$52.6K |
|
|
TRST
584
Trustco Bank Corp NY
TRST
$977M
| $1.39M | 0.02% |
35,098
| – | – |
|
585
Park-Ohio Holdings
PKOH
$554M
| $1.39M | 0.02% |
42,507
+4,750
| +13% | +$162K |
|
|
SYKE
586
DELISTED
SYKES Enterprises Inc
SYKE
| $1.39M | 0.02% |
50,442
+1,210
| +2% | +$32.6K |
|
587
American Public Education
APEI
$875M
| $1.38M | 0.02% |
46,709
+34,438
| +281% | +$1.05M |
|
|
CNR
588
Core Natural Resources Inc
CNR
$4.19B
| $1.38M | 0.02% |
51,790
+5,230
| +11% | +$156K |
|
589
Enphase Energy
ENPH
$4.84B
| $1.36M | 0.02% |
74,875
| – | – |
|
590
Lamar Advertising Co
LAMR
$16.2B
| $1.35M | 0.02% |
+16,700
| New | +$1.35M |
|
|
CRCM
591
DELISTED
CARE.COM, INC.
CRCM
| $1.34M | 0.02% |
122,099
-68,775
| -36% | -$1.04M |
|
592
CACI
CACI
$10.8B
| $1.34M | 0.02% |
6,550
+1,410
| +27% | +$279K |
|
|
AAMI
593
Acadian Asset Management
AAMI
$2.88B
| $1.33M | 0.02% |
+116,602
| New | +$1.48M |
|
|
SCS
594
DELISTED
Steelcase
SCS
| $1.31M | 0.02% |
76,906
-46,800
| -38% | -$779K |
|
595
Metropolitan Bank Holding Corp
MCB
$1.13B
| $1.31M | 0.02% |
29,693
+4,650
| +19% | +$185K |
|
596
lululemon athletica
LULU
$13B
| $1.3M | 0.02% |
+7,220
| New | +$1.25M |
|
597
SM Energy
SM
$7.96B
| $1.3M | 0.02% |
+103,700
| New | +$1.51M |
|
598
Standex International
SXI
$3.68B
| $1.29M | 0.02% |
17,708
-1,660
| -9% | -$117K |
|
|
WCG
599
DELISTED
Wellcare Health Plans, Inc.
WCG
| $1.29M | 0.02% |
4,524
| – | – |
|
600
GoPro
GPRO
$116M
| $1.29M | 0.02% |
235,500
-91,800
| -28% | -$584K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2019 Portfolio in Review
As of Q2 2019, Jacobs Levy Equity Management held 1,100 positions worth $7.23B, up 4.3% from $6.93B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jacobs Levy Equity Management's Q2 2019 filing shows 151 new, 415 increased, 333 reduced and 164 closed positions. Its largest new stake was Biogen: 175,817 shares worth $41.1M. The largest sale was Allergan plc, an estimated $51.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2019 buy was Biogen: 175,817 shares worth $41.1M.
- Jacobs Levy Equity Management added most to Ecolab in Q2 2019, an estimated $35.6M increase.
- Jacobs Levy Equity Management's biggest Q2 2019 reduction was EOG Resources, cutting an estimated $33.8M.
- Jacobs Levy Equity Management fully exited Allergan plc in Q2 2019, selling an estimated $51.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 15% of its $7.23B portfolio in Q2 2019.
- Jacobs Levy Equity Management opened 151 new positions and closed 164 in Q2 2019.
- Jacobs Levy Equity Management's portfolio value rose 4.3% quarter-over-quarter to $7.23B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2019, filed 13 Aug 2019.